| 000 | 01056 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514070526.0 | ||
| 264 | 0 | _c20030612 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 024 | 7 |
_a10.1001/jama.289.20.2646-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEvans, George W | |
| 245 | 0 | 0 |
_aLiability for adverse events in direct-to-consumer advertising. _h[electronic resource] |
| 260 |
_bJAMA _cMay 2003 |
||
| 300 |
_a2646-7; author reply 2647 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAdvertising _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Industry _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug Prescriptions |
| 650 | 0 | 4 | _aLiability, Legal |
| 650 | 0 | 4 | _aPatient Participation |
| 650 | 0 | 4 | _aPhysician-Patient Relations |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aFriede, Arnold I | |
| 773 | 0 |
_tJAMA _gvol. 289 _gno. 20 _gp. 2646-7; author reply 2647 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.289.20.2646-b _zAvailable from publisher's website |
| 999 |
_c12557379 _d12557379 |
||